microRNA (miRNA)-mediated transformation of cancer cell transcriptomes underlies pathogenic mechanisms and potential therapeutic approaches. Using miRNAs for cancer therapeutics, however, has encountered roadblocks in terms of delivery efficacy, toxicity, and immunogenicity. In this webinar brought to you by The Scientist, Andrea Kasinski and Masako Harada will explore new ways to overcome these challenges and discuss how they develop more effective miRNA delivery strategies.
Topics to be covered
Ligand-based miRNA delivery
Using extracellular vesicles for targeted microRNA delivery
Tuesday, February 8, 2022
2:30 - 4:00 PM Eastern Time
Meet the speakers
Andrea Kacinski, PhD Associate Professor Biological Sciences Purdue University
Masako Harada, PhD Assistant Professor
Biomedical Engineering Michigan State University
Sponsored by
Register
TS_Webinar_Bio-Rad_LabTools_Droplet Digital PCR: When qPCR Doesn’t Make the Cut November 4, 2021_IO#403220
You must have Javascript and Cookies enabled to access this webcast.
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
